Avidity biosciences announces upcoming presentations at the 75th american academy of neurology annual meeting

San diego, april 17, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced presentations at the 75th american academy of neurology (aan) annual meeting, including an oral presentation on the topline safety, biomarker and functional data from the aoc 1001 phase 1/2 marina™ trial. the 75th aan annual meeting is taking place in boston, mass., april 22-27, 2023.
RNA Ratings Summary
RNA Quant Ranking